195 related articles for article (PubMed ID: 26194191)
1. Loss of Stromal IMP1 Promotes a Tumorigenic Microenvironment in the Colon.
Hamilton KE; Chatterji P; Lundsmith ET; Andres SF; Giroux V; Hicks PD; Noubissi FK; Spiegelman VS; Rustgi AK
Mol Cancer Res; 2015 Nov; 13(11):1478-86. PubMed ID: 26194191
[TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional regulation of colonic epithelial repair by RNA binding protein IMP1/IGF2BP1.
Chatterji P; Williams PA; Whelan KA; Samper FC; Andres SF; Simon LA; Parham LR; Mizuno R; Lundsmith ET; Lee DS; Liang S; Wijeratne HS; Marti S; Chau L; Giroux V; Wilkins BJ; Wu GD; Shah P; Tartaglia GG; Hamilton KE
EMBO Rep; 2019 Jun; 20(6):. PubMed ID: 31061170
[TBL] [Abstract][Full Text] [Related]
3. Grifolin, neogrifolin and confluentin from the terricolous polypore Albatrellus flettii suppress KRAS expression in human colon cancer cells.
Yaqoob A; Li WM; Liu V; Wang C; Mackedenski S; Tackaberry LE; Massicotte HB; Egger KN; Reimer K; Lee CH
PLoS One; 2020; 15(5):e0231948. PubMed ID: 32369483
[TBL] [Abstract][Full Text] [Related]
4. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155 deletion promotes tumorigenesis in the azoxymethane-dextran sulfate sodium model of colon cancer.
Velázquez KT; Enos RT; McClellan JL; Cranford TL; Chatzistamou I; Singh UP; Nagarkatti M; Nagarkatti PS; Fan D; Murphy EA
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G347-58. PubMed ID: 26744471
[TBL] [Abstract][Full Text] [Related]
6. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis.
Koliaraki V; Roulis M; Kollias G
J Clin Invest; 2012 Nov; 122(11):4231-42. PubMed ID: 23064365
[TBL] [Abstract][Full Text] [Related]
7. IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts.
Hamilton KE; Noubissi FK; Katti PS; Hahn CM; Davey SR; Lundsmith ET; Klein-Szanto AJ; Rhim AD; Spiegelman VS; Rustgi AK
Carcinogenesis; 2013 Nov; 34(11):2647-54. PubMed ID: 23764754
[TBL] [Abstract][Full Text] [Related]
8. Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS).
Thaker AI; Shaker A; Rao MS; Ciorba MA
J Vis Exp; 2012 Sep; (67):. PubMed ID: 22990604
[TBL] [Abstract][Full Text] [Related]
9. Dietary selenium deficiency exacerbates DSS-induced epithelial injury and AOM/DSS-induced tumorigenesis.
Barrett CW; Singh K; Motley AK; Lintel MK; Matafonova E; Bradley AM; Ning W; Poindexter SV; Parang B; Reddy VK; Chaturvedi R; Fingleton BM; Washington MK; Wilson KT; Davies SS; Hill KE; Burk RF; Williams CS
PLoS One; 2013; 8(7):e67845. PubMed ID: 23861820
[TBL] [Abstract][Full Text] [Related]
10. The B-cell tumor promoter Bcl-3 suppresses inflammation-associated colon tumorigenesis in epithelial cells.
Tang W; Wang H; Ha HL; Tassi I; Bhardwaj R; Claudio E; Siebenlist U
Oncogene; 2016 Dec; 35(48):6203-6211. PubMed ID: 27132515
[TBL] [Abstract][Full Text] [Related]
11. IGF2BP1/IMP1 Deletion Enhances a Facultative Stem Cell State via Regulation of MAP1LC3B.
Parham LR; Williams PA; Katada K; Nettleford SK; Chatterji P; Acheampong KK; Danan CH; Ma X; Simon LA; Naughton KE; Mizuno R; Karakasheva T; McMillan EA; Whelan KA; Brady DC; Shaffer SM; Hamilton KE
Cell Mol Gastroenterol Hepatol; 2024; 17(3):439-451. PubMed ID: 38081361
[TBL] [Abstract][Full Text] [Related]
12. Epimorphin deletion inhibits polyposis in the Apcmin/+ mouse model of colon carcinogenesis via decreased myofibroblast HGF secretion.
Swietlicki EA; Bala S; Lu J; Shaker A; Kularatna G; Levin MS; Rubin DC
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(8):G564-72. PubMed ID: 23886856
[TBL] [Abstract][Full Text] [Related]
13. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer.
Means AL; Freeman TJ; Zhu J; Woodbury LG; Marincola-Smith P; Wu C; Meyer AR; Weaver CJ; Padmanabhan C; An H; Zi J; Wessinger BC; Chaturvedi R; Brown TD; Deane NG; Coffey RJ; Wilson KT; Smith JJ; Sawyers CL; Goldenring JR; Novitskiy SV; Washington MK; Shi C; Beauchamp RD
Cell Mol Gastroenterol Hepatol; 2018; 6(3):257-276. PubMed ID: 30109253
[TBL] [Abstract][Full Text] [Related]
14. IMP1/IGF2BP1 in human colorectal cancer extracellular vesicles.
Kuhn M; Zhang Y; Favate J; Morita M; Blucher A; Das S; Liang S; Preet R; Parham LR; Williams KN; Molugu S; Armstrong RJ; Zhang W; Yang J; Hamilton KE; Dixon DA; Mills G; Morgan TK; Shah P; Andres SF
Am J Physiol Gastrointest Liver Physiol; 2022 Dec; 323(6):G571-G585. PubMed ID: 36194131
[TBL] [Abstract][Full Text] [Related]
15. The neurotensin receptor-1 promotes tumor development in a sporadic but not an inflammation-associated mouse model of colon cancer.
Bugni JM; Rabadi LA; Jubbal K; Karagiannides I; Lawson G; Pothoulakis C
Int J Cancer; 2012 Apr; 130(8):1798-805. PubMed ID: 21630261
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C-α is upregulated by IMP1 in melanoma and is linked to poor survival.
Mahapatra L; Andruska N; Mao C; Gruber SB; Johnson TM; Fullen DR; Raskin L; Shapiro DJ
Melanoma Res; 2019 Oct; 29(5):539-543. PubMed ID: 30543563
[TBL] [Abstract][Full Text] [Related]
17. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
[TBL] [Abstract][Full Text] [Related]
18. Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancer.
Dimitriadis E; Trangas T; Milatos S; Foukas PG; Gioulbasanis I; Courtis N; Nielsen FC; Pandis N; Dafni U; Bardi G; Ioannidis P
Int J Cancer; 2007 Aug; 121(3):486-94. PubMed ID: 17415713
[TBL] [Abstract][Full Text] [Related]
19. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract][Full Text] [Related]
20. Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice.
Hansen TV; Hammer NA; Nielsen J; Madsen M; Dalbaeck C; Wewer UM; Christiansen J; Nielsen FC
Mol Cell Biol; 2004 May; 24(10):4448-64. PubMed ID: 15121863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
